1Benjamin B, Gaurav K, Ling R, et al. Expression of the cytoskeleton linker protein ezrin in human caricers [J]. Clin Exp Metastasis, 2007,24 (2) : 69-78.
4Gemma D, Javier S, Jose MS, et al. Clinicopathological characteristics of breast carcinomas with alielic loss in the p73 region [J].Breast Cancer ResTreat, 2000,63 (1) : 17-22.
二级参考文献10
1HUNTER K W.Ezrin,a key component in tumor metastasis[J].Trends Mol Med,2004,10 (5):201 -204.
2WENG W H,AHLEN J,ASTROM K,et al.Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas[J].Clinical Cancer Research,2005,11 (17):6 198 -6 204.
3AKISAWA N,NISHIMORI I,IWAMURA T,et al.High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential[J].Biochem Biophys Res Commun,1999,258(2):395-400.
4YU Y,KHAN J,KHANNA C,et al.Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators[J].Nat Med,2004,10(2):175 -181.
5MATHEW J,HINES J E,OBAFUNWA J O,et al.CD44 is expressed in hepatocellular carcinomas showing vascular invasion[J].J Pathol,1996,179(1):74 -79.
6OHTANI K,SAKAMOTO H,RUTHERFORD T,et al.Ezrin,a membrane-cytoskeletal linking protein,is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma[J].Cancer Lett,2002,179(1):79-86.
7FUKAYA Y,ISHIGURO N,SENGA T,et al.A role for PI3K-Akt signaling in pulmonary metastatic nodule formation of the osteosarcoma cell line,LM8[J].Oncol ogy Reports,2005,14(4):847-852.
8LUGINI L,LOZUPONE F,MATARRESE P,et al.Potent phagocytic activitydiscriminate metastatic and primary human malignant melanoma:a keyrole of ezrin[J].Lab Invest,2003,83 (11):1 555 -1 567.
